Advertisements


Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan

Aerie (AERI) begins dosing in a phase II study on netarsudil ophthalmic solution in Japan for curbing high intraocular pressure in patients with open-angle glaucoma or ocular hyperten.....»»

Category: worldSource: nytMar 22nd, 2019

Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan

Aerie (AERI) begins dosing in a phase II study on netarsudil ophthalmic solution in Japan for curbing high intraocular pressure in patients with open-angle glaucoma or ocular hyperten.....»»

Category: worldSource: nytMar 22nd, 2019

Eyenovia Initiates Phase III Study for Mydriasis Candidate

Eyenovia (EYEN) starts enrollment in the first phase III study of a two clinical study program to evaluate its mydriasis candidate, MicroStat. Stock rallies. .....»»

Category: worldSource: nytNov 27th, 2018

BioMarin provides update of Phase 1/2 study of hemophilia A candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 19th, 2021

Moderna sees Phase 1 study of mRNA flu vaccine candidate to begin in 2021

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

Moderna shares plans for Phase 3 study of CMV vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2021

Relmada Therapeutics begins second Phase 3 study of antidepressant candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2021

Pfizer starts early-stage study of oral COVID-19 treatment

Shares of Pfizer Inc. were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 cl.....»»

Category: topSource: marketwatchMar 23rd, 2021

Salarius Starts Expansion Phase Of Seclidemstat Study In Bones/Soft Tissues Cancer

read more.....»»

Category: blogSource: benzingaFeb 24th, 2021

Sanofi, GSK initiate Phase 2 study of COVID-19 vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 22nd, 2021

Regulus completes enrollment in Phase 1b study of ADPKD candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2021

I-MAB"s Phase 1 study of cancer candidate cleared by China"s NMPA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 10th, 2021

Cue Biopharma initiates dosing in Phase 1 study of cancer candidate CUE-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 8th, 2021

Brickell announces Japan Phase 3 study results for sofpironium bromide gel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 19th, 2021

Novavax starts Phase 3 COVID vaccine trial with plans to enroll 30,000 volunteers in U.S. and Mexico

Novavax Inc. said Monday it is starting a late-stage trial of its COVID-19 vaccine candidate with plans to enroll up to 30,000 volunteers at about 115 sites in .....»»

Category: topSource: marketwatchDec 28th, 2020

: CureVac starts Phase 3 clinical trial of its COVID-19 vaccine candidate

Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America......»»

Category: topSource: marketwatchDec 14th, 2020

Pfizer, BioNTech COVID-19 vaccine candidate study in Germany support safety profile

Pfizer Inc. and its Germany-based partner BioNTech SE said overall results of a Phase 1/2 study in Germany of its COVID-19 vaccine candidate, BNT162b2, mirrored .....»»

Category: topSource: marketwatchDec 14th, 2020

Moderna Applies For Phase 2 Study Of Coronavirus Vaccine Candidate

Moderna I.....»»

Category: blogSource: benzingaApr 28th, 2020

Pfizer reports results from Phase 3 study of 20vPnC candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2020

Sellas Life Sciences starts Phase 3 REGAL study of Galinpepimut-S

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Madrigal Pharmaceuticals doses first patient in Phase 3 study of NASH candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 18th, 2019